Atopic dermatitis (AD) is a chronic inflammatory skin disease that predominantly affects children (1), but that can persist or start in adulthood (2,3). The diagnosis of adult AD is sometimes difficult; indeed, it can present with atypical clinical phenotypes (4). Dupilumab, is a recent valid therapeutic option for adult AD patients (5,6). As AD is a chronic disease, it is important for clinicians following patient's response to treatments.
Dermoscopic assessment of long-term systemic therapy with dupilumab in adult atopic dermatitis / Ferrillo, M; Patruno, C; Villani, A; Scalvenzi, M; Fabbrocini, G; D'Andrea, M; Napolitano, M. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - (2020). [10.1111/jdv.16409]
Dermoscopic assessment of long-term systemic therapy with dupilumab in adult atopic dermatitis
Ferrillo, M;Patruno, C;Villani, A;Scalvenzi, M;Fabbrocini, G;D'Andrea, M;Napolitano, M
2020
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin disease that predominantly affects children (1), but that can persist or start in adulthood (2,3). The diagnosis of adult AD is sometimes difficult; indeed, it can present with atypical clinical phenotypes (4). Dupilumab, is a recent valid therapeutic option for adult AD patients (5,6). As AD is a chronic disease, it is important for clinicians following patient's response to treatments.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
